Annual Shareholders Equity
$5.07 B
+$399.78 M+8.56%
December 31, 2022
Summary
- As of February 7, 2025, HZNP annual stockholders equity is $5.07 billion, with the most recent change of +$399.78 million (+8.56%) on December 31, 2022.
- During the last 3 years, HZNP annual shareholders equity has risen by +$2.89 billion (+132.09%).
Performance
HZNP Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$5.31 B
+$215.40 M+4.23%
June 30, 2023
Summary
- As of February 7, 2025, HZNP quarterly stockholders equity is $5.31 billion, with the most recent change of +$215.40 million (+4.23%) on June 30, 2023.
- Over the past year, HZNP quarterly shareholders equity has increased by +$365.43 million (+7.39%).
Performance
HZNP Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
HZNP Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +8.6% | +7.4% |
3 y3 years | +132.1% | +124.9% |
5 y5 years | +406.6% | +517.5% |
HZNP Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | -7.9% | at high | -12.0% |
5 y | 5-year | at high | -56.9% | at high | -58.9% |
alltime | all time | at high | -101.0% | at high | -104.3% |
Horizon Therapeutics Public Limited Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Jun 2023 | - | $5.31 B(+4.2%) |
Mar 2023 | - | $5.10 B(+0.5%) |
Dec 2022 | $5.07 B(+8.6%) | $5.07 B(+0.8%) |
Sep 2022 | - | $5.03 B(+1.8%) |
Jun 2022 | - | $4.95 B(+2.7%) |
Mar 2022 | - | $4.82 B(+3.1%) |
Dec 2021 | $4.67 B(+16.1%) | $4.67 B(+5.0%) |
Sep 2021 | - | $4.45 B(+9.2%) |
Jun 2021 | - | $4.07 B(+5.7%) |
Mar 2021 | - | $3.85 B(-4.2%) |
Dec 2020 | $4.03 B(+84.2%) | $4.03 B(+6.0%) |
Sep 2020 | - | $3.80 B(+60.8%) |
Jun 2020 | - | $2.36 B(+7.9%) |
Mar 2020 | - | $2.19 B(+0.1%) |
Dec 2019 | $2.19 B(+83.6%) | $2.19 B(+40.5%) |
Sep 2019 | - | $1.56 B(+2.3%) |
Jun 2019 | - | $1.52 B(+1.1%) |
Mar 2019 | - | $1.50 B(+26.4%) |
Dec 2018 | $1.19 B(+18.9%) | $1.19 B(+29.8%) |
Sep 2018 | - | $916.86 M(+6.6%) |
Jun 2018 | - | $860.15 M(-0.1%) |
Mar 2018 | - | $861.10 M(-14.0%) |
Dec 2017 | $1.00 B(-20.8%) | $1.00 B(+0.1%) |
Sep 2017 | - | $999.82 M(-2.8%) |
Jun 2017 | - | $1.03 B(-14.7%) |
Mar 2017 | - | $1.21 B(-4.6%) |
Dec 2016 | $1.26 B | $1.26 B(-7.2%) |
Sep 2016 | - | $1.36 B(+1.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2016 | - | $1.34 B(+3.6%) |
Mar 2016 | - | $1.29 B(-1.6%) |
Dec 2015 | $1.31 B(+143.1%) | $1.31 B(+4.4%) |
Sep 2015 | - | $1.26 B(+0.3%) |
Jun 2015 | - | $1.25 B(+82.3%) |
Mar 2015 | - | $687.96 M(+27.4%) |
Dec 2014 | $540.20 M(-1200.6%) | $540.20 M(+11.3%) |
Sep 2014 | - | $485.49 M(+501.8%) |
Jun 2014 | - | $80.67 M(-135.2%) |
Mar 2014 | - | -$229.24 M(+367.1%) |
Dec 2013 | -$49.08 M(-146.3%) | -$49.08 M(-170.2%) |
Sep 2013 | - | $69.89 M(-0.6%) |
Jun 2013 | - | $70.31 M(-16.4%) |
Mar 2013 | - | $84.09 M(-20.7%) |
Dec 2012 | $105.98 M(+130.8%) | $105.98 M(-17.5%) |
Sep 2012 | - | $128.42 M(+121.9%) |
Jun 2012 | - | $57.87 M(-29.3%) |
Mar 2012 | - | $81.81 M(+78.2%) |
Dec 2011 | $45.91 M(-52.7%) | $45.91 M(-63.7%) |
Sep 2011 | - | $126.33 M(+41.5%) |
Jun 2011 | - | $89.31 M(-7.8%) |
Mar 2011 | - | $96.85 M(-0.2%) |
Dec 2010 | $97.06 M(-3155.0%) | $97.06 M(-9.6%) |
Sep 2010 | - | $107.38 M(-9.7%) |
Jun 2010 | - | $118.97 M(-1282.1%) |
Mar 2010 | - | -$10.06 M(+216.8%) |
Dec 2009 | -$3.18 M(-62.4%) | -$3.18 M |
Dec 2008 | -$8.45 M | - |
FAQ
- What is Horizon Therapeutics Public Limited annual stockholders equity?
- What is the all time high annual shareholders equity for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited annual shareholders equity year-on-year change?
- What is Horizon Therapeutics Public Limited quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited quarterly shareholders equity year-on-year change?
What is Horizon Therapeutics Public Limited annual stockholders equity?
The current annual shareholders equity of HZNP is $5.07 B
What is the all time high annual shareholders equity for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high annual stockholders equity is $5.07 B
What is Horizon Therapeutics Public Limited annual shareholders equity year-on-year change?
Over the past year, HZNP annual stockholders equity has changed by +$399.78 M (+8.56%)
What is Horizon Therapeutics Public Limited quarterly stockholders equity?
The current quarterly shareholders equity of HZNP is $5.31 B
What is the all time high quarterly shareholders equity for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high quarterly stockholders equity is $5.31 B
What is Horizon Therapeutics Public Limited quarterly shareholders equity year-on-year change?
Over the past year, HZNP quarterly stockholders equity has changed by +$365.43 M (+7.39%)